Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 12/20 | 0.38 |
| ▸ | REN | P00797 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 2/20 | 0.36 |
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP7 | P09237 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29165756 | 0.93 | CCKAR (0.36) | BACE1MMP2MMP7MMP9MMP12 | |
| SCHEMBL28167878 | 0.89 | BACE1 (0.39) | BACE1RENECE1CTSDHRH1 | |
| SCHEMBL29591626 | 0.86 | BACE1 (0.41) | BACE1CTSD | |
| SCHEMBL29630322 | 0.86 | BACE1 (0.41) | BACE1CTSD | |
| SCHEMBL873298 | 0.85 | BACE1 (0.36) | BACE1RENECE1CTSD | |
| SCHEMBL30192164 | 0.84 | BACE1 (0.36) | BACE1ECE1CTSD | |
| SCHEMBL31073567 | 0.84 | BACE1 (0.42) | BACE1CTSDMMP2MMP7MMP9 | |
| SCHEMBL30360293 | 0.83 | ECE1 (0.41) | BACE1ECE1 | |
| SCHEMBL29630564 | 0.83 | SLC15A2 (0.43) | RENECE1MMP2MMP7MMP9 | |
| SCHEMBL29429284 | 0.83 | SLC15A2 (0.40) | ECE1MMP2MMP7MMP9MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10758490-B2 | Nanocapsules containing microemulsions | LIPOTEC, S.A. (ES) | 2020-09-01 | — | — | US | claimed |
| EP-4340807-B1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MAT INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20240252419-A1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-08-01 | — | — | US | disclosed |
| EP-4340807-A1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | Lubrizol Advanced Materials, Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-2022245758-A1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-11-24 | — | — | WO | disclosed |
| US-11478412-B2 | Hair modification composition and method therefor | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| EP-3212688-B1 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | LUBRIZOL ADVANCED MAT INC (US) | 2022-04-13 | — | — | EP | disclosed |
| US-20210154120-A1 | HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2021-05-27 | — | — | US | disclosed |
| CN-107108837-B | Thermoplastic polyurethane films for delivering active agents to skin surfaces | 路博润先进材料公司 | 2021-04-13 | — | — | CN | disclosed |
| EP-3773458-A1 | HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR | Lubrizol Advanced Materials, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| EP-2618926-B1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC SA (ES) | 2019-05-08 | — | — | EP | disclosed |
| US-20180311358-A1 | THERMOFORMABLE DUAL NETWORK HYDROGEL COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. | 2018-11-01 | — | — | US | disclosed |
| EP-3371238-A1 | THERMOFORMABLE DUAL NETWORK HYDROGEL COMPOSITIONS | Lubrizol Advanced Materials, Inc. (US) | 2018-09-12 | — | — | EP | disclosed |
| US-20170319462-A1 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | LUBRIZOL ADVANCED MATERIALS, INC. | 2017-11-09 | — | — | US | disclosed |
| EP-3212688-A2 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | Lubrizol Advanced Materials, Inc. (US) | 2017-09-06 | — | — | EP | disclosed |
| WO-2017079248-A1 | THERMOFORMABLE DUAL NETWORK HYDROGEL COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2017-05-11 | — | — | WO | disclosed |
| WO-2016069396-A2 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2016-05-06 | — | — | WO | disclosed |
| US-20130216596-A1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC, S.A. (ES) | 2013-08-22 | — | — | US | disclosed |
| EP-2618926-A2 | NANOCAPSULES CONTAINING MICROEMULSIONS | Lipotec, S.A. (ES) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012038061-A2 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC, S.A. (ES) | 2012-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11478412-B2 | Hair modification composition and method therefor | DSC1, HADHB, PHOSPHO1 | BACE1 1365/4885REN 4159/4885ECE1 4596/4885 |
| US-20210154120-A1 | HAIR MODIFICATION COMPOSITION AND METHOD THEREFOR | DSC1, HADHB, PHOSPHO1 | BACE1 1365/4885REN 4159/4885ECE1 4596/4885 |
| US-20240252419-A1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | TYR, DOT1L, CUTA | BACE1 3874/4885REN 691/4885ECE1 3739/4885 |
| US-20180311358-A1 | THERMOFORMABLE DUAL NETWORK HYDROGEL COMPOSITIONS | HSF1, DUOX2, HSPA2 | BACE1 4752/4885REN 4616/4885ECE1 3951/4885 |
| US-20170319462-A1 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | DNER, CUTA, PUF60 | BACE1 3091/4885REN 4686/4885ECE1 518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.